Safety Assessments in
Pre-Clinical Studies

Your full-service cell and gene biosafety partner

As a full-service cell and gene biosafety partner, GeneWerk provides clarity on the safety of the therapies in development very early on in the process.

Our GCLP-compliant services – from sample preparation to report delivery – are designed to help you to meet pre-clinical safety standards for emerging gene therapies.

Get in touch

We help you answer the questions that matter

Our comprehensive services for pre-clinical safety assessment include integration site analysis, vector persistence testing, clonal expansion, vector integration profiling, gene editing on-/off-target analysis, vector copy number (VCN), vector quality control, and immune repertoire analysis.

These services combined with our dedicated bioinformatics pipelines enable precise decision-making to successfully navigate the regulatory landscape.

Want to get in touch?

Consult with our experts about solutions to your biosafety challenges.

Contact us

Latest news

Read our latest press releases and announcements below.

Protagen Protein Services merges with GeneWerk

Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand...

Read More

GeneWerk Announces Growth Equity Investment from Ampersand…

GeneWerk will expand capabilities to meet rapidly growing demand for cell and gene therapy...

Read More

Insight into Spatial and Temporal Trends of…

Genewerk GmbH in collaboration with University Heidelberg Germany provided an insight into spatial and...

Read More

GeneWerk in the Holiday Park

A little fun for everyone! This year’s company trip took us to the Holiday...

Read More
I agree to the Privacy Policy and Terms of Service.